These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass. Lee GM; Welsby IJ; Phillips-Bute B; Ortel TL; Arepally GM Blood; 2013 Apr; 121(15):2828-35. PubMed ID: 23422751 [TBL] [Abstract][Full Text] [Related]
3. Platelet-activating protamine-heparin-antibodies lead to higher protamine demand in patients undergoing cardiac surgery. Grieshaber P; Bakchoul T; Wilhelm J; Wagner A; Wollbrück M; Böning A; Sachs U J Thorac Cardiovasc Surg; 2015 Oct; 150(4):967-73.e1. PubMed ID: 26298870 [TBL] [Abstract][Full Text] [Related]
4. Protamine (heparin)-induced thrombocytopenia: a review of the serological and clinical features associated with anti-protamine/heparin antibodies. Bakchoul T; Jouni R; Warkentin TE J Thromb Haemost; 2016 Sep; 14(9):1685-95. PubMed ID: 27378603 [TBL] [Abstract][Full Text] [Related]
5. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. Selleng S; Malowsky B; Strobel U; Wessel A; Ittermann T; Wollert HG; Warkentin TE; Greinacher A J Thromb Haemost; 2010 Jan; 8(1):30-6. PubMed ID: 19793190 [TBL] [Abstract][Full Text] [Related]
6. Serological features of antibodies to protamine inducing thrombocytopenia and thrombosis. Panzer S; Schiferer A; Steinlechner B; Drouet L; Amiral J Clin Chem Lab Med; 2015 Feb; 53(2):249-55. PubMed ID: 25153412 [TBL] [Abstract][Full Text] [Related]
7. Incidence of antibodies to protamine sulfate/heparin complexes incardiac surgery patients and impact on platelet activation and clinical outcome. Pouplard C; Leroux D; Rollin J; Amiral J; May MA; Gruel Y Thromb Haemost; 2013 Jun; 109(6):1141-7. PubMed ID: 23636177 [TBL] [Abstract][Full Text] [Related]
8. Partially desulfated heparin modulates the interaction between anti-protamine/heparin antibodies and platelets. Jouni R; Zöllner H; Khadour A; Wesche J; Grotevendt A; Brandt S; Delcea M; Krauel K; Schwertz H; Sachs UJ; Greinacher A; Bakchoul T Thromb Haemost; 2016 Jan; 115(2):324-32. PubMed ID: 26423467 [TBL] [Abstract][Full Text] [Related]
9. Antibodies against heparin-protamine complexes: Effect and clinical relevance. Beckerman Z; Cohen O J Thorac Cardiovasc Surg; 2015 Oct; 150(4):974-5. PubMed ID: 26320779 [No Abstract] [Full Text] [Related]
15. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia. Pouplard C; May MA; Iochmann S; Amiral J; Vissac AM; Marchand M; Gruel Y Circulation; 1999 May; 99(19):2530-6. PubMed ID: 10330384 [TBL] [Abstract][Full Text] [Related]
16. High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery. Trossaërt M; Gaillard A; Commin PL; Amiral J; Vissac AM; Fressinaud E Br J Haematol; 1998 Jun; 101(4):653-5. PubMed ID: 9674736 [TBL] [Abstract][Full Text] [Related]
17. Increased accuracy in heparin and protamine administration decreases bleeding: a pilot study. Runge M; Møller CH; Steinbrüchel DA J Extra Corpor Technol; 2009 Mar; 41(1):10-4. PubMed ID: 19361026 [TBL] [Abstract][Full Text] [Related]
18. A case series of recombinant platelet factor 4 for heparin reversal after cardiopulmonary bypass. Demma L; Levy JH Anesth Analg; 2012 Dec; 115(6):1273-8. PubMed ID: 22859690 [TBL] [Abstract][Full Text] [Related]
19. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery. Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844 [TBL] [Abstract][Full Text] [Related]
20. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial. Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]